Study Evaluating AGG-523 in Subjects With Severe Osteoarthritis Requiring Total Knee Replacement
Clinical trial NCT00454298 · COMPLETED
Trial details
- NCT number
- NCT00454298
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2008-03-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.